News and Announcements

GSK secures EMA review for single‑dose Bexsero booster

By Iain Gilbert

Date: Monday 20 Jul 2026

(Sharecast News) - Drugmaker GSK said on Monday that the European Medicines Agency had accepted its submission to update the label for its Bexsero asset, allowing for a single‑dose booster in people aged 10 and over who were previously vaccinated in childhood.
GSK said that, if approved, the booster would enable...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page